Fatemeh Fekrmandi, MD, MSc Fatemeh Fekrmandi, MD, MSc

Fatemeh Fekrmandi

MD, MSc
Radiation Oncology

Specializing In:

Radiation Oncology

About Fatemeh Fekrmandi

Positions

Roswell Park Comprehensive Cancer Center

  • Radiation Medicine Resident Physician
  • Clinical Assistant Instructor, Health Sciences
  • Department of Radiation Medicine

Background

Education and Training:

  • 2015 - MSc - Experimental Medicine, Cancer Genetics, McGill University, Montreal, Quebec, Canada
  • 2012 - MD - Zanjan University of Medical Sciences, Zanjan, Iran

Residency:

  • 2021-2025 - Radiation Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
  • 2020-2021 - Internal Medicine Preliminary Year, Catholic Health System, State University of New York At Buffalo, Buffalo, NY

Professional Memberships:

  • American Board of Radiology
  • American Society for Radiation Oncology

Professional Experience:

  • 2015-2019 - Research Associate, Radiation Oncology Department, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada
  • 2013-2015 - Research Assistant, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada

Honors & Awards:

  • 2012 - Summa Cum Laude, Zanjan University of Medical Sciences
  • 2012 - MedTech Challenge, Campus des technologies de la santé
  • 2010 - Iranian National Medical Olympiads, Basic Sciences: Stem Cells

Publications

Association of survival with stereotactic body radiation therapy following induction chemotherapy for unresected locally advanced pancreatic cancer.
S Ma, L Serra, A Bartl, H Han, F Fekrmandi, A Iovoli, K Prezzano, G Hermann, H Yu, A Singh
Journal of Radiotherapy in Practice
2021 | journal-article
DOI: 10.1017/S1460396921000212

Evaluation of adjuvant radiation and endocrine therapy in elderly patients with early-stage breast cancer.
SJ Ma, B Yu, OT Oladeru, AJ Bartl, M Farrugia, F Fekrmandi, AK Singh
The breast journal
2021 | journal-article
DOI: 10.1111/tbj.14228

Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.
Gynecologic Oncology
HQ Rana, L Kipnis, K Hehir, A Cronin, T Jaung, SM Stokes, F Fekrmandi, D Vatnick, UA Matulonis, JE Garber, AA Wright
2021 | journal-article
DOI: 10.1016/j.ygyno.2020.11.003

Predictive factors for persistent and late radiation complications in breast cancer survivors.
Clinical and Translational Oncology
F Fekrmandi, T Panzarella, RE Dinniwell, J Helou, W Levin
2020 | journal-article
DOI: 10.1007/s12094-019-02133-8

The hormone-bound Vitamin D receptor enhances the FBW7-dependent turnover of NF-κB subunits.
Scientific Reports
F Fekrmandi, TT Wang, JH White
2015 | journal-article
DOI: 10.1038/srep13002